The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Incyte (I)
Consulting or Advisory Role - Incyte (I)
Research Funding - GlaxoSmithKline; Millennium; Novartis; Others; Sanofi
Expert Testimony - Abbvie
Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer (mCRC) treated with ziv-aflibercept (Z) in community oncology practices in the United States (US).
 
Jasmina I Ivanova
Employment - Boehringer Ingelheim (I)
Research Funding - Sanofi (Inst)
 
Kimberly Saverno
Employment - Humana (I); Vector Oncology
Stock and Other Ownership Interests - Humana (I)
Consulting or Advisory Role - Humana (I); Vector Oncology
Research Funding - Humana (I); Vector Oncology
 
Jennifer Sung
Employment - Sanofi
Stock and Other Ownership Interests - Novartis; Sanofi
 
Mei Sheng Duh
No Relationships to Disclose
 
Chen Zhao
Research Funding - Sanofi (Inst)
 
Xiaopeng Cai
Research Funding - Sanofi (Inst)
 
Francis Vekeman
Stock and Other Ownership Interests - DaVita; Express Scripts; Valeant Pharmaceuticals International
Research Funding - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Lundbeck; Novartis; Sanofi
 
Aaron Peevyhouse
Employment - Vector Oncology
Research Funding - Vector Oncology
Travel, Accommodations, Expenses - GTx
 
Ravinder Dhawan
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Charles S. Fuchs
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Lilly; MedImmune; Merck; Pfizer; Roche Pharma AG; Sanofi; Takeda; Vertex